Zealand Pharma — Oktober 2022
-
Zealand Pharma major shareholder announcement: Polar Capital
Zealand Pharma major shareholder announcement: Polar Capital
Company announcement – No. 47 / 2022 Zealand Pharma major shareholder announcement: Polar Capital Copenhagen, Denmark and Boston, MA, 11 October...
GlobeNewswire News Room (www.globenewswire.com)
Zealand Pharma: Polar Capital ejer 11,51 pct. aktier
-
-
Fonde under Polar Capital : https://www.polarcapital.co.uk/gb/professional/Our-Funds/Funds-Overview/#
-
Godmorgen.
-
Godmorgen.
-
Zealand Pharma/Jefferies: Kursmål hæves til 205 kr. fra 165 kr. - NY https://www.proinvestor.com/investornyt/889239/zealand-pharma-jefferies-kursmal-haeves-til-205-kr-fra-165-kr-ny
-
Aktier/tendens: Chr. Hansen kan stjæle fokus - C25 ses åbne rødt - NY https://www.proinvestor.com/investornyt/889256/aktier-tendens-chr-hansen-kan-stjaele-fokus-c25-ses-abne-rodt-ny
-
Mornings - spændende om momentum fortsætter i dag - mit højre knæ visker snart-200:)
-
hvisker...omg
-
-
Michael Novod’s rapport i dag: Zealand Pharma - Buy/DKK 245: Amgen rallies 6%, adding USD ~7bn to its market cap on a ph I obesity asset - shows exactly how underappreciated the Zealand obesity pipeline is.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind